1. Home
  2. APM vs GSUN Comparison

APM vs GSUN Comparison

Compare APM & GSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • GSUN
  • Stock Information
  • Founded
  • APM 2010
  • GSUN 1997
  • Country
  • APM United Kingdom
  • GSUN China
  • Employees
  • APM N/A
  • GSUN N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • GSUN Other Consumer Services
  • Sector
  • APM Health Care
  • GSUN Real Estate
  • Exchange
  • APM Nasdaq
  • GSUN Nasdaq
  • Market Cap
  • APM 6.7M
  • GSUN N/A
  • IPO Year
  • APM 2018
  • GSUN 2022
  • Fundamental
  • Price
  • APM $0.88
  • GSUN $2.87
  • Analyst Decision
  • APM
  • GSUN
  • Analyst Count
  • APM 0
  • GSUN 0
  • Target Price
  • APM N/A
  • GSUN N/A
  • AVG Volume (30 Days)
  • APM 27.5K
  • GSUN 15.4K
  • Earning Date
  • APM 04-29-2025
  • GSUN 04-08-2025
  • Dividend Yield
  • APM N/A
  • GSUN N/A
  • EPS Growth
  • APM N/A
  • GSUN N/A
  • EPS
  • APM 0.00
  • GSUN N/A
  • Revenue
  • APM N/A
  • GSUN $10,159,020.00
  • Revenue This Year
  • APM $157,729.10
  • GSUN N/A
  • Revenue Next Year
  • APM N/A
  • GSUN N/A
  • P/E Ratio
  • APM $242.56
  • GSUN N/A
  • Revenue Growth
  • APM N/A
  • GSUN 65.04
  • 52 Week Low
  • APM $0.46
  • GSUN $2.21
  • 52 Week High
  • APM $11.19
  • GSUN $9.93
  • Technical
  • Relative Strength Index (RSI)
  • APM 42.47
  • GSUN 46.24
  • Support Level
  • APM $0.85
  • GSUN $2.80
  • Resistance Level
  • APM $1.00
  • GSUN $3.25
  • Average True Range (ATR)
  • APM 0.07
  • GSUN 0.21
  • MACD
  • APM 0.00
  • GSUN -0.02
  • Stochastic Oscillator
  • APM 39.15
  • GSUN 24.00

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: